161 related articles for article (PubMed ID: 14619443)
1. [Evidence of indications of influenza vaccine and its efficacy--including Guillain-Barré syndrome as an adverse reaction(?)].
Watanabe A
Nihon Rinsho; 2003 Nov; 61(11):1987-91. PubMed ID: 14619443
[TBL] [Abstract][Full Text] [Related]
2. [Vaccination against influenza and Guillain-Barre syndrome: are there any relations?].
Wiercińska-Drapało A; Grzeszczuk A; Wasilewski K; Prokopowicz D
Pol Merkur Lekarski; 2000 May; 8(47):360-1. PubMed ID: 10944963
[TBL] [Abstract][Full Text] [Related]
3. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
[TBL] [Abstract][Full Text] [Related]
4. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.
Lasky T; Terracciano GJ; Magder L; Koski CL; Ballesteros M; Nash D; Clark S; Haber P; Stolley PD; Schonberger LB; Chen RT
N Engl J Med; 1998 Dec; 339(25):1797-802. PubMed ID: 9854114
[TBL] [Abstract][Full Text] [Related]
5. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
[TBL] [Abstract][Full Text] [Related]
6. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].
Press R; Andersen O
Lakartidningen; 2010 Mar 10-16; 107(10):666-7. PubMed ID: 20402249
[No Abstract] [Full Text] [Related]
7. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.
Kwong JC; Vasa PP; Campitelli MA; Hawken S; Wilson K; Rosella LC; Stukel TA; Crowcroft NS; McGeer AJ; Zinman L; Deeks SL
Lancet Infect Dis; 2013 Sep; 13(9):769-76. PubMed ID: 23810252
[TBL] [Abstract][Full Text] [Related]
8. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Guillain-Barré Syndrome among recipients of influenza vaccine in 2000 and 2001.
Burwen DR; Ball R; Bryan WW; Izurieta HS; La Voie L; Gibbs NA; Kliman R; Braun MM
Am J Prev Med; 2010 Oct; 39(4):296-304. PubMed ID: 20837279
[TBL] [Abstract][Full Text] [Related]
10. Values for preventing influenza-related morbidity and vaccine adverse events in children.
Prosser LA; Bridges CB; Uyeki TM; Rêgo VH; Ray GT; Meltzer MI; Schwartz B; Thompson WW; Fukuda K; Lieu TA
Health Qual Life Outcomes; 2005 Mar; 3():18. PubMed ID: 15780143
[TBL] [Abstract][Full Text] [Related]
11. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study.
Zinman L; Thoma J; Kwong JC; Kopp A; Stukel TA; Juurlink DN
Muscle Nerve; 2009 Dec; 40(6):947-51. PubMed ID: 19902540
[TBL] [Abstract][Full Text] [Related]
12. Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience.
Iskander J; Broder K
Expert Rev Vaccines; 2008 Feb; 7(1):75-82. PubMed ID: 18251695
[TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009).
Souayah N; Yacoub HA; Khan HM; Farhad K; Mehyar LS; Maybodi L; Menkes DL; Qureshi AI
J Clin Neuromuscul Dis; 2012 Dec; 14(2):66-71. PubMed ID: 23172385
[TBL] [Abstract][Full Text] [Related]
14. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005).
Souayah N; Nasar A; Suri MF; Qureshi AI
J Clin Neuromuscul Dis; 2009 Sep; 11(1):1-6. PubMed ID: 19730016
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Guillain-Barré syndrome, influenza-related hospitalizations, and influenza vaccine coverage.
Iqbal S; Li R; Gargiullo P; Vellozzi C
Vaccine; 2015 Apr; 33(17):2045-9. PubMed ID: 25749247
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System.
Souayah N; Nasar A; Suri MF; Qureshi AI
Vaccine; 2007 Jul; 25(29):5253-5. PubMed ID: 17560693
[TBL] [Abstract][Full Text] [Related]
17. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
18. Guillain-Barré syndrome following H1N1 immunization in a pediatric patient.
Tremblay ME; Closon A; D'Anjou G; Bussières JF
Ann Pharmacother; 2010; 44(7-8):1330-3. PubMed ID: 20484170
[TBL] [Abstract][Full Text] [Related]
19. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study.
Juurlink DN; Stukel TA; Kwong J; Kopp A; McGeer A; Upshur RE; Manuel DG; Moineddin R; Wilson K
Arch Intern Med; 2006 Nov; 166(20):2217-21. PubMed ID: 17101939
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barre syndrome after influenza vaccine administration: two adult cases.
Bedard Marrero V; Osorio Figueroa RL; Vázquez Torres O
Bol Asoc Med P R; 2010; 102(2):39-41. PubMed ID: 20939203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
